Testosterone for Women: Who Actually Needs It and What to Expect

Why women have testosterone — and why it matters more than you've been told

Women produce three to four times more testosterone than estrogen by volume, across their reproductive years. It's not a trace hormone. It's a primary androgen, made in the ovaries and adrenal glands, and it does things in the female body that no other hormone does at the same doses.

Testosterone acts directly on the brain's sexual arousal circuits, on muscle tissue, on bone density, and on energy metabolism. Its decline in perimenopause is often steeper and earlier than estrogen's — which partly explains why low libido, fatigue, and difficulty maintaining muscle are frequently the first symptoms women notice, long before hot flashes arrive.

What the 2019 consensus actually says — and what it doesn't

The Global Consensus Statement on the Use of Testosterone Therapy for Women was published in the Journal of Sexual Medicine and co-signed by the American College of Obstetricians and Gynecologists, the Endocrine Society, the British Menopause Society, and dozens of others. It represents the clearest statement the field has produced.

What it endorses: testosterone supplementation for women with HSDD — hypoactive sexual desire disorder — specifically when estrogen levels are adequate, other causes have been ruled out, and the desire distress has a physiological basis. In this context, the evidence is strong, with multiple randomized trials showing improved sexual desire, arousal, and satisfaction.

What it does not endorse: testosterone as a general energy booster, a body composition tool, or a cognitive performance enhancer. The evidence for these uses is preliminary and not sufficient to support routine prescribing.

How it's prescribed — the practical reality

Because no FDA-approved female product exists, most US doctors prescribe male testosterone gel or cream at fractions of the male dose. A common approach: 1–10mg daily (men use 50–100mg), applied topically to the inner forearm or thigh. Pellet therapy is also offered by some clinics, though dosing is less precise and more difficult to adjust.

Blood level monitoring matters. The goal is to reach the upper range of normal female testosterone, not male levels. SHBG (sex hormone binding globulin) also needs to be checked — it affects how much testosterone is biologically active. A good prescribing doctor will measure both total testosterone and free testosterone at baseline and after 3–6 months.

The gap between good care and bad care here is wide. Clinics advertising "testosterone optimization for women" with aggressive pellet dosing and minimal monitoring are a different proposition from a menopause specialist titrating gel carefully with regular bloodwork.

Who it's most likely to help — and who it won't

Women who tend to respond best to testosterone therapy are those in natural or surgical menopause with confirmed low androgen levels, adequate estrogen (either through the body or supplemented), and whose primary complaint is loss of sexual desire rather than other sexual dysfunction like pain or arousal disorder. It's also used successfully in perimenopausal women whose testosterone decline is outpacing their estrogen decline.

It's less likely to help if low desire is primarily driven by relationship factors, depression, anxiety, medication side effects (SSRIs suppress libido significantly), or hypothyroidism. Those need to be addressed first — or alongside. Testosterone isn't a fix for everything that depletes desire, just for the component with a hormonal driver.